Developer docs
API playgroundTry for free, no card

Search company profiles

ContinuumRx

Full company profile

uuid0008ksx

Namestring
ContinuumRx
Legal namestring
ContinuumRx
Websiteurl
continuumrx.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

ContinuumRx is a private home and alternate-site infusion therapy and specialty pharmacy provider founded in 2001 and headquartered in Birmingham, Alabama. The company administers a portfolio of clinical services — antibiotic therapy, enteral nutrition, total parenteral nutrition (TPN), IVIG, heart failure therapy (including inotropes such as milrinone and dobutamine), and biologic therapies — delivered either directly to patient homes or through six physical infusion centers located in Alabama, Tennessee, Virginia, and Ohio. Underlying technology is clinical rather than software: pharmacy compounding operations, sterile IV preparation, durable medical equipment provision, and 24/7 on-call pharmacy and delivery coverage, supported by ACHC and PCAB accreditation and a digital portal of specialty medication referral forms.

The company monetizes primarily through insurance reimbursement (commercial carriers, Medicare Part B covering ~80% of therapy cost, and Medicaid), with commercial home infusion rates running 40–60% below hospital-based equivalents and saving an estimated $1,928–$2,974 per treatment course. Its go-to-market is sales-led and partnership-driven, anchored by 40+ hospital and health system referral relationships — including Ascension, UAB Medicine, Inova, Erlanger, Huntsville Hospital, and the University of Tennessee Medical Center — supplemented by physician referrals, a coordinated discharge workflow, and a wholly-owned subsidiary (Continuum Health) that operates spa-like infusion facilities. The company operates as a subsidiary of Acelpa Health following a 2024 consolidation, led by CEO Keith P. Hartman, and serves patients across 14 southeastern and mid-Atlantic U.S. states.

Short descriptiontext

ContinuumRx is a Birmingham-based home and alternate-site infusion therapy and specialty pharmacy provider that delivers IV antibiotics, TPN, IVIG, heart failure, and biologic therapies to patients across 14 southeastern and mid-Atlantic U.S. states through hospital partnerships, home visits, and six infusion centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBirmingham, United States
HQ citystring
Birmingham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home infusion therapy, specialty pharmacy services, post-acute care coordination, biologic infusion therapies, sterile compounding pharmacy
Industry4 codes
PRIMARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFAEAE
Home Infusion Therapy Providers
SECONDARYHSABALAG
Injectables & Specialty Medication Support (e.g., insulin, biologics)
Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support
SECONDARYHSABALAH
In-Home Infusion Pharmacy Support & Coordination
Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support
NAICS code1 code
  • Home Health Care Services621610
SIC code1 code
  • Services-Home Health Care Services8082
Product category
Home Infusion Therapy and Specialty Pharmacy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Pharmacy and Infusion Services
TypeManaged Services
Description

ContinuumRx generates revenue through providing home and site-based infusion therapies billed to commercial insurance, Medicare Part B, and Medicaid. Services include antibiotic therapy, parenteral/enteral nutrition, IVIG, heart failure therapy, and biologic therapies. Commercial insurers typically reimburse at 40-60% less than hospital costs. The company recently became in-network with United Healthcare and accepts nearly all insurance carriers including state Medicaid for out-of-state patients in emergencies.

continuumrx.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Continuum Health
Description

Wholly-owned subsidiary providing full-service, relaxing infusion facilities with spa-like patient environment.

continuumrx.com
Core offering1 text field

ContinuumRx delivers home and site-based infusion therapy and specialty pharmacy services to patients requiring complex IV treatments, partnering with health systems to coordinate post-acute care. Core clinical offerings include IV antibiotic therapy, enteral and parenteral nutrition, IVIG, heart failure inotropic therapy, and biologic/specialty medications, supported by clinical nursing, sterile compounding, durable medical equipment, and 24/7 on-call coverage across 14 southeastern and mid-Atlantic U.S. states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Home infusion saves $1,928 to $2,974 per treatment course compared to medical setting infusion costs
+1 more record
Product overview1 text field

ContinuumRx is a specialty pharmacy and home infusion services provider offering a unified portfolio of clinical care services. The core offerings include Antibiotic Therapy, Enteral Nutrition (tube feeding), Parenteral Nutrition (TPN), IVIG Therapy, Heart Failure Therapy, and Biologic Therapies. These services are delivered through home infusion and alternate site-based infusion suites, supported by patient education materials and medical devices like the Elastomeric Infusion Device. The company serves patients throughout the Greater Southeastern U.S. with infusion centers in Alabama, Tennessee, Virginia, and Ohio.

Product and service7 records
1Antibiotic Therapy
CategoryHome infusion therapy
Description

Home intravenous antibiotic therapy service that administers short- and long-term IV antibiotics, allowing patients to avoid unnecessary hospitalization.

2Enteral Nutrition
3Parenteral Nutrition (TPN)
4Immunoglobulin Therapy (IVIG)
5Heart Failure Therapy
6Biologic Therapies and Specialty Medications
7Continuum Health Infusion Facilities
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-19
Description

Collaboration with NHC (NYSE: NHC) to provide COVID-19 bamlanivimab infusion treatments to high-risk patients in long-term care facilities. Partnership formed as part of NHIA pilot program with Operation Warp Speed. NHC operates nearly 100 nursing centers across 10 states.

2Ascension Saint Thomas
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major health system partnership providing integrated specialty infusion services and seamless patient transitions from hospital to home care settings.

continuumrx.com
3Ascension St. Vincent's
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health system partnership for post-acute care coordination and home infusion services.

continuumrx.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic medical center partnership providing integrated specialty infusion services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Home infusion partnership with regional health system for patient discharge and home care services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional hospital partnership for home infusion therapy coordination.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major health system partnership in Virginia region for integrated infusion services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic health system partnership providing integrated specialty infusion and care coordination.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with home health agencies for IV and subcutaneous antibody therapy administration. Nurses from partner agencies provide continuity of care for trained patients.

Strategic tierCoreTypeOthers
Description

ContinuumRx is now an Acelpa Health company, operating as a subsidiary with shared leadership and branding.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest independent provider of home and alternate-site infusion services in the U.S., formed via the 2019 BioScrip merger. Directly comparable to ContinuumRx in core services (home infusion, specialty pharmacy, infusion suites), but operates at national scale.

TypeDirect peer
Description

Specialty infusion and home infusion provider focused on IVIG, biologics, and complex therapies. Highly comparable specialty drug portfolio and home/ambulatory delivery model.

TypeDirect peer
Description

Specialty infusion provider offering home and alternate-site IV therapy, including TPN, IVIG, and antibiotics. Comparable scale and service mix; operates as a privately held national platform.

TypeDirect peer
Description

Franchise-based home and alternate-site infusion pharmacy network. Competes with ContinuumRx for the same patient population (IV antibiotics, biologics, nutrition support) with a regional-clinic delivery model.

TypeBroad incumbent
Description

Home infusion and specialty pharmacy division of CVS Health. Offers the same core services as ContinuumRx (IVIG, antibiotics, TPN, biologics) but as part of a national retail/specialty pharmacy platform with much broader payer reach.

6Pentec Health
TypeDirect peer
Description

Specialty infusion and nutrition provider, with particular strength in TPN and renal therapies. Comparable in clinical complexity and home-delivery model.

TypeOthers
Description

Industry association of which ContinuumRx is a member. Not a competitor, but the dominant trade body shaping home infusion accreditation, reimbursement policy, and clinical standards — directly relevant to ContinuumRx's regulatory environment.

TypeDirect peer
Description

National home infusion provider specializing in IVIG, biologics, and acute/chronic infusion therapies. Closest mid-market private peer to ContinuumRx in service mix, clinical complexity, and specialty drug focus.

TypeBroad incumbent
Description

Specialty and home infusion pharmacy within OptumRx / UnitedHealth Group. Highly comparable service mix to ContinuumRx; competes for the same specialty drug referrals and benefits from United's payer scale.

TypeRegional player
Description

Specialty infusion and home infusion provider concentrated in the U.S. Southwest. Comparable services (biologics, IVIG, antibiotics, TPN) but regional rather than Southeast-focused like ContinuumRx.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ContinuumRx

Home Infusion Therapy and Specialty Pharmacy Servicescontinuumrx.com

ContinuumRx is a Birmingham-based home and alternate-site infusion therapy and specialty pharmacy provider that delivers IV antibiotics, TPN, IVIG, heart failure, and biologic therapies to patients across 14 southeastern and mid-Atlantic U.S. states through hospital partnerships, home visits, and six infusion centers.

What ContinuumRx does

ContinuumRx is a private home and alternate-site infusion therapy and specialty pharmacy provider founded in 2001 and headquartered in Birmingham, Alabama. The company administers a portfolio of clinical services — antibiotic therapy, enteral nutrition, total parenteral nutrition (TPN), IVIG, heart failure therapy (including inotropes such as milrinone and dobutamine), and biologic therapies — delivered either directly to patient homes or through six physical infusion centers located in Alabama, Tennessee, Virginia, and Ohio. Underlying technology is clinical rather than software: pharmacy compounding operations, sterile IV preparation, durable medical equipment provision, and 24/7 on-call pharmacy and delivery coverage, supported by ACHC and PCAB accreditation and a digital portal of specialty medication referral forms.

The company monetizes primarily through insurance reimbursement (commercial carriers, Medicare Part B covering ~80% of therapy cost, and Medicaid), with commercial home infusion rates running 40–60% below hospital-based equivalents and saving an estimated $1,928–$2,974 per treatment course. Its go-to-market is sales-led and partnership-driven, anchored by 40+ hospital and health system referral relationships — including Ascension, UAB Medicine, Inova, Erlanger, Huntsville Hospital, and the University of Tennessee Medical Center — supplemented by physician referrals, a coordinated discharge workflow, and a wholly-owned subsidiary (Continuum Health) that operates spa-like infusion facilities. The company operates as a subsidiary of Acelpa Health following a 2024 consolidation, led by CEO Keith P. Hartman, and serves patients across 14 southeastern and mid-Atlantic U.S. states.

ContinuumRx firmographics

Firmographics
Name
ContinuumRx
Legal name
ContinuumRx
Website
https://continuumrx.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Short description
ContinuumRx is a Birmingham-based home and alternate-site infusion therapy and specialty pharmacy provider that delivers IV antibiotics, TPN, IVIG, heart failure, and biologic therapies to patients across 14 southeastern and mid-Atlantic U.S. states through hospital partnerships, home visits, and six infusion centers.
Ownership category
akta.pro rank

ContinuumRx industry classification

Industry
Product category
Home Infusion Therapy and Specialty Pharmacy Services
NAICS
Home Health Care Services (621610)
SIC
Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFAEAE
Home Infusion Therapy Providers
SECONDARYHSABALAG
Injectables & Specialty Medication Support (e.g., insulin, biologics)
Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support
SECONDARYHSABALAH
In-Home Infusion Pharmacy Support & Coordination
Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support

Keywords

  • Home infusion therapy
  • Specialty pharmacy services
  • Post-acute care coordination
  • Biologic infusion therapies
  • Sterile compounding pharmacy

Where ContinuumRx is headquartered

Location

Headquarters

HQ city
Birmingham
HQ country
United States
HQ region
North America

Offices7 records

Markets served

ContinuumRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Specialty Pharmacy and Infusion Services: ContinuumRx generates revenue through providing home and site-based infusion therapies billed to commercial insurance, Medicare Part B, and Medicaid. Services include antibiotic therapy, parenteral/enteral nutrition, IVIG, heart failure therapy, and biologic therapies. Commercial insurers typically reimburse at 40-60% less than hospital costs. The company recently became in-network with United Healthcare and accepts nearly all insurance carriers including state Medicaid for out-of-state patients in emergencies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

ContinuumRx product offering

Product offering

Core offering

ContinuumRx delivers home and site-based infusion therapy and specialty pharmacy services to patients requiring complex IV treatments, partnering with health systems to coordinate post-acute care. Core clinical offerings include IV antibiotic therapy, enteral and parenteral nutrition, IVIG, heart failure inotropic therapy, and biologic/specialty medications, supported by clinical nursing, sterile compounding, durable medical equipment, and 24/7 on-call coverage across 14 southeastern and mid-Atlantic U.S. states.

Product overview

ContinuumRx is a specialty pharmacy and home infusion services provider offering a unified portfolio of clinical care services. The core offerings include Antibiotic Therapy, Enteral Nutrition (tube feeding), Parenteral Nutrition (TPN), IVIG Therapy, Heart Failure Therapy, and Biologic Therapies. These services are delivered through home infusion and alternate site-based infusion suites, supported by patient education materials and medical devices like the Elastomeric Infusion Device. The company serves patients throughout the Greater Southeastern U.S. with infusion centers in Alabama, Tennessee, Virginia, and Ohio.

Differentiator

Problem solved

Functional benefit

Brands

  • Continuum Health: Wholly-owned subsidiary providing full-service, relaxing infusion facilities with spa-like patient environment.

Products and services

  • Antibiotic Therapy Home intravenous antibiotic therapy service that administers short- and long-term IV antibiotics, allowing patients to avoid unnecessary hospitalization.
  • Enteral Nutrition
  • Parenteral Nutrition (TPN)
  • Immunoglobulin Therapy (IVIG)
  • Heart Failure Therapy
  • Biologic Therapies and Specialty Medications
  • Continuum Health Infusion Facilities

Quantifiable outcome

  • Home infusion saves $1,928 to $2,974 per treatment course compared to medical setting infusion costs
  • +1 more outcomes

Companies that use ContinuumRx

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

ContinuumRx technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ContinuumRx partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • National HealthCare Corporation (NHC)coreStrategic or Co-development Partner · 19 January 2021Collaboration with NHC (NYSE: NHC) to provide COVID-19 bamlanivimab infusion treatments to high-risk patients in long-term care facilities. Partnership formed as part of NHIA pilot program with Operation Warp Speed. NHC operates nearly 100 nursing centers across 10 states.
  • Ascension Saint ThomascoreStrategic or Co-development PartnerMajor health system partnership providing integrated specialty infusion services and seamless patient transitions from hospital to home care settings.
  • Ascension St. Vincent'scoreStrategic or Co-development PartnerHealth system partnership for post-acute care coordination and home infusion services.
  • The University of Tennessee Medical CentercoreStrategic or Co-development PartnerAcademic medical center partnership providing integrated specialty infusion services.
  • Erlanger Home InfusioncoreChannel Partner/ Reseller/ DistributorHome infusion partnership with regional health system for patient discharge and home care services.
  • Huntsville Hospital Home InfusioncoreChannel Partner/ Reseller/ DistributorRegional hospital partnership for home infusion therapy coordination.
  • InovacoreStrategic or Co-development PartnerMajor health system partnership in Virginia region for integrated infusion services.
  • UAB MedicinecoreStrategic or Co-development PartnerAcademic health system partnership providing integrated specialty infusion and care coordination.
  • Home Health AgenciesminorChannel Partner/ Reseller/ DistributorPartnership with home health agencies for IV and subcutaneous antibody therapy administration. Nurses from partner agencies provide continuity of care for trained patients.
  • Acelpa HealthcoreOthersContinuumRx is now an Acelpa Health company, operating as a subsidiary with shared leadership and branding.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

ContinuumRx competitors and assessment

Company assessment

Direct peers

  • Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S., formed via the 2019 BioScrip merger. Directly comparable to ContinuumRx in core services (home infusion, specialty pharmacy, infusion suites), but operates at national scale.
  • Soleo Health: Specialty infusion and home infusion provider focused on IVIG, biologics, and complex therapies. Highly comparable specialty drug portfolio and home/ambulatory delivery model.
  • Amerita: Specialty infusion provider offering home and alternate-site IV therapy, including TPN, IVIG, and antibiotics. Comparable scale and service mix; operates as a privately held national platform.
  • Vital Care Infusion Services: Franchise-based home and alternate-site infusion pharmacy network. Competes with ContinuumRx for the same patient population (IV antibiotics, biologics, nutrition support) with a regional-clinic delivery model.
  • Pentec Health: Specialty infusion and nutrition provider, with particular strength in TPN and renal therapies. Comparable in clinical complexity and home-delivery model.
  • KabaFusion: National home infusion provider specializing in IVIG, biologics, and acute/chronic infusion therapies. Closest mid-market private peer to ContinuumRx in service mix, clinical complexity, and specialty drug focus.

Broad incumbents

  • Coram CVS Health (Coram): Home infusion and specialty pharmacy division of CVS Health. Offers the same core services as ContinuumRx (IVIG, antibiotics, TPN, biologics) but as part of a national retail/specialty pharmacy platform with much broader payer reach.
  • BriovaRx (OptumRx): Specialty and home infusion pharmacy within OptumRx / UnitedHealth Group. Highly comparable service mix to ContinuumRx; competes for the same specialty drug referrals and benefits from United's payer scale.

Others

  • NHIA (National Home Infusion Association): Industry association of which ContinuumRx is a member. Not a competitor, but the dominant trade body shaping home infusion accreditation, reimbursement policy, and clinical standards — directly relevant to ContinuumRx's regulatory environment.

Regional players

  • Paragon Healthcare: Specialty infusion and home infusion provider concentrated in the U.S. Southwest. Comparable services (biologics, IVIG, antibiotics, TPN) but regional rather than Southeast-focused like ContinuumRx.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ContinuumRx social profiles

Digital presence

ContinuumRx compliance and trust

Trust signal

Compliance4 records

ContinuumRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ContinuumRx leadership team

Management profile

Number of profiles

Profiles13 records

ContinuumRx subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ContinuumRx funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ContinuumRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ContinuumRx

What does ContinuumRx do?

ContinuumRx delivers home and site-based infusion therapy and specialty pharmacy services to patients requiring complex IV treatments, partnering with health systems to coordinate post-acute care. Core clinical offerings include IV antibiotic therapy, enteral and parenteral nutrition, IVIG, heart failure inotropic therapy, and biologic/specialty medications, supported by clinical nursing, sterile compounding, durable medical equipment, and 24/7 on-call coverage across 14 southeastern and mid-Atlantic U.S. states.

Is ContinuumRx a public or private company?

ContinuumRx is a private company. It is classified as corporate owned and is currently operating.

When was ContinuumRx founded?

ContinuumRx was founded in 2003. It employs 101 to 250 people.

Where is ContinuumRx based?

ContinuumRx is headquartered in Birmingham, United States, in the North America region.

How does ContinuumRx make money?

One revenue line is on record: specialty Pharmacy and Infusion Services.

Who are ContinuumRx's main competitors?

Direct peers on record are Option Care Health, Soleo Health, Amerita, Vital Care Infusion Services, Pentec Health and KabaFusion. Broad incumbents are Coram CVS Health (Coram) and BriovaRx (OptumRx). NHIA (National Home Infusion Association) is listed as an others. Paragon Healthcare is listed as a regional player.

Does ContinuumRx have an API?

No public API is recorded for ContinuumRx.

What industry is ContinuumRx in?

ContinuumRx's product category is Home Infusion Therapy and Specialty Pharmacy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFAEAE, Home Infusion Therapy Providers. Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireContinuumRx Announces Promotion of COO, Keith Hartman, to Chief Executive OfficerContinuumRx announced the immediate promotion of COO Keith Hartman to Chief Executive Officer, succeeding Todd Timbrook who will remain on the board. The company reported nearly 40% growth over the past three years and expanded hospital partnerships across Alabama, Tennessee, and Virginia. Hartman aims to leverage shifts in Medicare and hospital-to-home practices to further drive growth.MedCity NewsInova Health System and ContinuumRX launch JVInova Health System and ContinuumRX formed a joint venture to supply home infusion and specialty pharmacy services to patients in northern Virginia and nearby areas. Services begin this fall, aiming to improve discharge efficiency and reduce readmissions. The JV expects to service a significant portion of all patients leaving the hospital.PR NewswireInova Health System and ContinuumRX™ Form Healthcare Joint VentureInova Health System and ContinuumRX announced a joint venture to provide home infusion and specialty pharmacy services in northern Virginia, with services launching this fall. The venture aims to improve patient outcomes, reduce readmissions, and lower healthcare costs.PR NewswireInova Health System and ContinuumRX™ Form Healthcare Joint VentureInova Health System and ContinuumRX announced an agreement to form a joint venture providing home infusion and specialty pharmacy services to patients across northern Virginia and surrounding areas, with operations planned to launch in fall 2017. The partnership aims to improve patient outcomes, reduce unnecessary hospital readmissions, and transition patients to lower-cost clinically appropriate care settings. Both organizations view this integrated model as a way to enhance efficiency at discharge and enable better monitoring of patient outcomes across home infusion therapy types.VC News DailyContinuumRx Receives $13.5MContinuumRx, a Birmingham-based home infusion services company, has closed a $13.5 million financing round led by New Spring Capital, with existing investors contributing an additional $2.0 million in new capital and converting $4.5 million of debt to equity.FinSMEsContinuumRx Closes $7M FinancingContinuumRx, a Birmingham-based company, closed $7M in financing from Mitsui & Co., Health Enterprise Partners, Fidelis Capital, Redmont Venture Partners, and Stonehenge Capital. The company will use the capital to expand in the southeastern U.S., serving eight healthcare systems across Tennessee, Mississippi, and Alabama.VC News DailyContinuumRx Closes $7 MContinuumRx has closed on $7 million in new financing led by Mitsui & Co. Global Investment, with participation from Health Enterprise Partners, Fidelis Capital Partners, Redmont Venture Partners, and Stonehenge Capital Company. The capital will be used to fund continued growth throughout the southeastern U.S., where the company currently operates joint ventures with eight major healthcare systems across 30 hospitals and medical centers in Tennessee, Mississippi, and Alabama. The company's CEO noted that securing growth capital from quality investors is vital to its long-term goals.